Boris Peaker News Today

Lilly set Dec. 15 as the deadline in a third extension. The Indianapolis-based drugmaker maintained its offer price at $12.50 per share, which is over 10% lower than Point Biopharma's last closing price of $13.80. Lilly had struck a $1.4 billion deal to buy Point Biopharma in October.

(Reuters) - Eli Lilly on Monday again extended its deadline for Point Biopharma Global shareholders to sell their shares to the drugmaker, following ...

Operator: Greetings, and welcome to the Celcuity Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.

TD Cowen analyst Boris Peaker has maintained their bullish stance on IMGN stock, giving a Buy rating on October 20. Boris Peaker’s Buy ra...

Operator: Good afternoon, ladies and gentlemen, and welcome to the Celcuity Second Quarter 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode.

MGNX earnings call for the period ending June 30, 2023.

Operator: Hello, and welcome to the ADC Therapeutics Second Quarter 2023 Financial Results Conference Call. My name is Corey, and Ill be your operator for todays call.

EBS earnings call for the period ending June 30, 2023.